论文部分内容阅读
目的探讨中医(TCM)结合介入化疗治疗中晚期原发性肝癌的临床价值。方法59例中晚期原发性肝癌随机分为介入化疗组(29例)和中医+介入化疗组(30例),比较两组的疗效差异。结果中医结合介入化疗组的有效率(60.0%)明显高于单纯介入化疗组(27.6%)(χ2=6.28,P<0.05);介入化疗组的症状改善率为58.6%,而中医结合介入化疗组为83.3%(χ2=4.390,P<0.05);中医结合介入化疗组的毒副反应发生率较单纯介入组明显减少(χ2=6.16,P<0.05)。结论中医结合介入化疗治疗中晚期肝癌是一种安全、有效的方法,值得临床进一步推广。
Objective To investigate the clinical value of traditional Chinese medicine (TCM) combined with interventional chemotherapy in the treatment of advanced primary liver cancer. Methods Fifty-nine patients with advanced primary hepatocellular carcinoma (HCC) were randomly divided into interventional chemotherapy group (29 cases) and TCM + interventional chemotherapy group (30 cases). The curative effects were compared between the two groups. Results The effective rate (60.0%) in interventional chemotherapy group was significantly higher than that in interventional chemotherapy group (χ2 = 6.28, P <0.05). The rate of symptom improvement in interventional chemotherapy group was 58.6% Group was 83.3% (χ2 = 4.390, P <0.05). The incidence of toxic and side effects in the combination chemotherapy group was significantly lower than that in the simple intervention group (χ2 = 6.16, P <0.05). Conclusion Chinese medicine combined with interventional chemotherapy in the treatment of advanced liver cancer is a safe and effective method, it is worth further clinical promotion.